Expression of Lysine-specific demethylase 1 in human epithelial ovarian cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Expression of Lysine-specific demethylase 1 in human epithelial ovarian cancer ; volume:8 ; number:1 ; day:9 ; month:5 ; year:2015 ; pages:1-8 ; date:12.2015
Journal of ovarian research ; 8, Heft 1 (9.5.2015), 1-8, 12.2015
- Urheber
-
Chen, Cong
Ge, Jing
Lu, Qibin
Ping, Guoqiang
Yang, Chunqing
Fang, Xuefeng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-015-0155-1
- URN
-
urn:nbn:de:101:1-2021090318513533817236
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
05.08.2025254, 16:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Cong
- Ge, Jing
- Lu, Qibin
- Ping, Guoqiang
- Yang, Chunqing
- Fang, Xuefeng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
Molecular mechanisms involved in lysine-specific demethylase 1 mediated oncogenic stress
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
Role of lysine-specific histone demethylase 1a for kidney development and maintenance
Lysine-specific demethylase 1 regulates differentiation onset and migration of trophoblast stem cells
Lysine-specific histone demethylase 1 (LSD1): a novel molecular target for tumor therapy
The oncogenic role of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases
Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases
The Role of the Lysine-Specific Demethylase 1 in the Development of Hepatocellular Carcinoma
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
Molecular mechanisms involved in lysine-specific demethylase 1 mediated oncogenic stress
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
Role of lysine-specific histone demethylase 1a for kidney development and maintenance
Lysine-specific demethylase 1 regulates differentiation onset and migration of trophoblast stem cells
Lysine-specific histone demethylase 1 (LSD1): a novel molecular target for tumor therapy
The oncogenic role of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases
Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases
The Role of the Lysine-Specific Demethylase 1 in the Development of Hepatocellular Carcinoma
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
Molecular mechanisms involved in lysine-specific demethylase 1 mediated oncogenic stress
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
Role of lysine-specific histone demethylase 1a for kidney development and maintenance
Lysine-specific demethylase 1 regulates differentiation onset and migration of trophoblast stem cells
Lysine-specific histone demethylase 1 (LSD1): a novel molecular target for tumor therapy
The oncogenic role of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases
Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases